2024 ICD-10-CM Diagnosis Code T37.4X1S
Poisoning by anthelminthics, accidental (unintentional), sequela
- ICD-10-CM Code:
- T37.4X1S
- ICD-10 Code for:
- Poisoning by anthelminthics, accidental, sequela
- Is Billable?
- Yes - Valid for Submission
- Chronic Condition Indicator: [1]
- Not chronic
- Code Navigator:
- Code Information
- Approximate Synonyms
- Clinical Classification
- Clinical Information
- Coding Guidelines
- Tabular List of Diseases and Injuries
- Diagnostic Related Groups Mapping
- Present on Admission (POA)
- Convert to ICD-9 Code
- Table of Drugs and Chemicals
- Patient Education
- Other Codes Used Similar Conditions
- Code History
T37.4X1S is a billable diagnosis code used to specify a medical diagnosis of poisoning by anthelminthics, accidental (unintentional), sequela. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
T37.4X1S is a sequela code, includes a 7th character and should be used for complications that arise as a direct result of a condition like poisoning by anthelminthics accidental (unintentional). According to ICD-10-CM Guidelines a "sequela" code should be used for chronic or residual conditions that are complications of an initial acute disease, illness or injury. The most common sequela is pain. Usually, two diagnosis codes are needed when reporting sequela. The first code describes the nature of the sequela while the second code describes the sequela or late effect.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Accidental piperazine and/or piperazine derivative poisoning
- Accidental piperazine overdose
- Accidental thiabendazole overdose
- Accidental thiabendazole poisoning
- Anthelmintic drug overdose
- Piperazine overdose
- Poisoning by thiabendazole
- Poisoning caused by piperazine and/or piperazine derivative
- Thiabendazole overdose
Clinical Classification
Clinical Category is Poisoning/toxic effect/adverse effects/underdosing, sequela
- CCSR Category Code: INJ075
- Inpatient Default CCSR: Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.
- Outpatient Default CCSR: Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.
Clinical Information
Albendazole
a benzimidazole broad-spectrum anthelmintic structurally related to mebendazole that is effective against many diseases. (from martindale, the extra pharmacopoeia, 30th ed, p38)Chenopodium
a plant genus in the chenopodiaceae family.Chenopodium album
a plant species in the chenopodium genus known for edible greens.Chenopodium ambrosioides
a plant species of the genus chenopodium known for toxicity to intestinal worms and other simple organisms.Chenopodium quinoa
a species of the chenopodium genus which is the source of edible seed called quinoa. it contains makisterone a and other steroids, some having ecdysteroid activity on insects.2,6-Dichloroindophenol
a dye used as a reagent in the determination of vitamin c.Dichlorophen
nontoxic laxative vermicide effective for taenia infestation. it tends to produce colic and nausea. it is also used as a veterinary fungicide, anthelmintic, and antiprotozoan. (from merck, 11th ed.)Diethylcarbamazine
an anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with wucheria bancrofti or loa loa.Fenbendazole
antinematodal benzimidazole used in veterinary medicine.Ivermectin
a mixture of mostly avermectin h2b1a (rn 71827-03-7) with some avermectin h2b1b (rn 70209-81-3), which are macrolides from streptomyces avermitilis. it binds glutamate-gated chloride channel to cause increased permeability and hyperpolarization of nerve and muscle cells. it also interacts with other chloride channels. it is a broad spectrum antiparasitic that is active against microfilariae of onchocerca volvulus but not the adult form.Levamisole
an antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and t-lymphocyte function. paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (from smith and reynard, textbook of pharmacology, 1991, p435-6)Lucanthone
one of the schistosomicides, it has been replaced largely by hycanthone and more recently praziquantel. (from martindale the extrapharmacopoeia, 30th ed., p46)Mebendazole
a benzimidazole that acts by interfering with carbohydrate metabolism and inhibiting polymerization of microtubules.Niclosamide
an antihelmintic that is active against most tapeworms. (from martindale, the extra pharmacopoeia, 30th ed, p48)Niridazole
an antischistosomal agent that has become obsolete.Oxamniquine
an anthelmintic with schistosomicidal activity against schistosoma mansoni, but not against other schistosoma spp. oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (from martindale, the extra pharmacopoeia, 31st ed, p121)Diketopiperazines
piperazines with two keto oxygens.Piperazine
an anti-nematodal agent effective against the intestinal nematodes ascaris lumbricoides (roundworm) and enterobius vermicularis (pinworm, threadworm). it produces a neuromuscular block leading to flaccid muscle paralysis in susceptible worms, which are then dislodged from the gut and expelled in feces.Piperazines
compounds that are derived from piperazine.Praziquantel
an anthelmintic used in most schistosome and many cestode infestations.Pyrantel
a depolarizing neuromuscular-blocking agent, that causes persistent nicotinic activation resulting in spastic paralysis of susceptible nematodes. it is a drug of second-choice after benzimidazoles for treatment of ascariasis, hookworm, and pinworm infections, being effective after a single dose. (from smith and reynard, textbook of pharmacology, 1992, p920)Pyrantel Pamoate
broad spectrum antinematodal anthelmintic used also in veterinary medicine.Pyrantel Tartrate
broad spectrum anthelmintic for livestock.Santonin
anthelmintic isolated from the dried unexpanded flower heads of artemisia maritima and other species of artemisia found principally in russian and chinese turkestan and the southern ural region. (from merck, 11th ed.)Tetramisole
Thiabendazole
2-substituted benzimidazole first introduced in 1962. it is active against a variety of nematodes and is the drug of choice for strongyloidiasis. it has central nervous system side effects and hepatototoxic potential. (from smith and reynard, textbook of pharmacology, 1992, p919)
Coding Guidelines
When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined. If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of other systemic anti-infectives and antiparasitics (T37). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Present on Admission (POA)
T37.4X1S is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
CMS POA Indicator Options and Definitions
POA Indicator | Reason for Code | CMS will pay the CC/MCC DRG? |
---|---|---|
Y | Diagnosis was present at time of inpatient admission. | YES |
N | Diagnosis was not present at time of inpatient admission. | NO |
U | Documentation insufficient to determine if the condition was present at the time of inpatient admission. | NO |
W | Clinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission. | YES |
1 | Unreported/Not used - Exempt from POA reporting. | NO |
Convert T37.4X1S to ICD-9-CM
- ICD-9-CM Code: 909.0 - Late eff drug poisoning
Combination Flag - Multiple codes are needed to describe the source diagnosis code. Correct coding should be done based on contextual judgment. - ICD-9-CM Code: E929.2 - Late eff acc poisoning
Combination Flag - Multiple codes are needed to describe the source diagnosis code. Correct coding should be done based on contextual judgment.
Table of Drugs and Chemicals
The parent code T37.4X1 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.
According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.
Patient Education
Medication Errors
Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:
- Knowing your medicines. When you get a prescription, ask the name of the medicine and check to make sure that the pharmacy gave you the right medicine. Make sure that you understand how often you should take the medicine and how long you should take it.
- Keeping a list of medicines.
- Write down all of the medicines that you are taking, including the names of your medicines, how much you take, and when you take them. Make sure to include any over-the-counter medicines, vitamins, supplements, and herbs that you take.
- List the medicines that you are allergic to or that have caused you problems in the past.
- Take this list with you every time you see a health care provider.
- Reading medicine labels and following the directions. Don't just rely on your memory - read the medication label every time. Be especially careful when giving medicines to children.
- Asking questions. If you don't know the answers to these questions, ask your health care provider or pharmacist:
- Why am I taking this medicine?
- What are the common side effects?
- What should I do if I have side effects?
- When should I stop this medicine?
- Can I take this medicine with the other medicines and supplements on my list?
- Do I need to avoid certain foods or alcohol while taking this medicine?
Food and Drug Administration
[Learn More in MedlinePlus]
Code History
- FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.